Laboratory of Yohan Bossé
Dr. Bossé and his team use modern genomic approaches to understand the molecular basis of heart and lung diseases. They also work with colleagues to organize large and diverse biological sample collections necessary for genomic health research, to develop relevant projects to fill the gaps between the diagnostic and treatment of diseases, and most importantly, to ensure point-of-care implementation of new genomic knowledge.
The main goal of this laboratory is to drive genomic research in the field of heart and lung diseases and translate scientific discoveries into new clinical uses to personalize the management and treatment of patients affected with these diseases.
Dec 2022: Identified TMB as a biomarker of lung cancer in never smokers. See our paper in Cancer Epidemiology, Biomarkers & Prevention.
Oct 2022: Evaluated the prognostic value of complex glandular patterns in lung adenocarcinomas. See our paper in the Human Pathology.
Jun 2022: Identified a new genetic mechanism causing alpha-1 antitryspin deficiency. See our paper in the American Journal of Respiratory Cell and Molecular Biology.
The LORD Retreat
May 9-10, 2023